• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG PROGAV W/DISTAL CATHETER; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG PROGAV W/DISTAL CATHETER; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV417T
Medical Device Problem Code Mechanical Problem (1384)
Health Effect - Clinical Code Hydrocephalus (3272)
Date of Event 10/09/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This complaint was reopened in reference to (b)(4).Manufacturing site evaluation: manufacturing and quality control data.The progav® was manufactured by a qualified employee in february 2016.Deviations during assembly did not occur.The valve was sterilized by miethke and released for shipment after final inspection.The progav® has a normal pressure range of 0 to 20 cmh20.The valve was inspected as article (b)(4).All parameters have been inspected and signed during the manufacturing process.All parameters have been assessed as meeting specification.Device examination: the progav® was returned submersed in an unidentified liquid in the provided return kit.Visual inspection: no significant deformations or damage of the valve were detected during the visual inspection.Permeability test: a permeability test has shown that the valve was permeable.Adjustment test: the progav® was tested and was adjustable to all specified pressures.Braking force and brake function test: the brake functionality test has shown that the brake function was fully operational and the braking force was within the given tolerances.Result: first, a visual inspection of the progav® was performed.No significant deformations or damage of the valve were detected.Next, the permeability, adjustability, as well as the brake functionally and brake force, of the valve were tested.The valve operated as expected and met all specifications.Finally, the valve was dismantled.A build-up of a substance (likely protein) was observed inside the valve.Based on the investigation, the claim of non-adjustability was not able to be substantiated.At the time of the investigation, no detectable failure was observed with this valve.However, it is possible that the deposits observed inside the valve could have led to the reported event.Deposits caused by natural substances in the cerebrospinal fluid, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.Manufacturing defects at the time of release have been excluded.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required.
 
Event or Problem Description
It was reported miethke that a progav w/distal catheter (part # (b)(4)) was implanted during a procedure performed on an unknown date.According to the complainant, the valve was not able to be adjusted.The patient underwent a revision procedure on (b)(6) 2017.The complaint device was returned to the manufacturer for evaluation.No patient complications were reported as a result of the revision procedure.Age: (b)(6), weight: (b)(6) (kg), height: 165 centimeters (cm), gender: unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV W/DISTAL CATHETER
Common Device Name
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
Manufacturer (Section G)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM   14469
Manufacturer Contact
joerg knebel
ulanenweg 2
potsdam, 14469
GM   14469
MDR Report Key13178875
Report Number3004721439-2021-00842
Device Sequence Number19973817
Product Code JXG
UDI-Device Identifier04041906132149
UDI-Public4041906132149
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
K103003
Number of Events Summarized1
Summary Report (Y/N)N
Device Explanted Year2017
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 01/06/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/31/2020
Device Model NumberFV417T
Device Catalogue NumberFV417T
Device Lot Number20029229
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/16/2017
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/17/2017
Initial Report FDA Received Date01/06/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/09/2016
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age50 YR
Patient SexUnknown
Patient Weight55 KG
-
-